(Q43462837)

23 November 2017

title

Dose-dependent alternations in the pharmacokinetics of olanzapine during coadministration of fluvoxamine in patients with schizophrenia (English)

1 reference

23 November 2017

1 reference

1 reference

1 reference

1

Chih-Chiang Chiu

1 reference

23 November 2017

3

Ming-Chyi Huang

1 reference

23 November 2017

Hsien-Yuan Lane

2

1 reference

23 November 2017

Hui-Ching Liu

4

1 reference

23 November 2017

Michael W Jann

5

1 reference

23 November 2017

Yuen-Yi Hon

6

1 reference

23 November 2017

Wen-Ho Chang

7

1 reference

23 November 2017

Mong-Liang Lu

8

1 reference

23 November 2017

publication date

1 December 2004

1 reference

The Journal of Clinical Pharmacology

23 November 2017

published in

1 reference

23 November 2017

volume

44

1 reference

23 November 2017

issue

12

1 reference

23 November 2017

page(s)

1385-1390

1 reference

Olanzapine. Pharmacokinetic and pharmacodynamic profile.

23 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0091270004270291

Investigation of target plasma concentration-effect relationships for olanzapine in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004270291

Therapeutic drug monitoring data on olanzapine and its N-demethyl metabolite in the naturalistic clinical setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004270291

Role of the smoking-induced cytochrome P450 (CYP)1A2 and polymorphic CYP2D6 in steady-state concentration of olanzapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004270291

Selective serotonin reuptake inhibitors and theophylline metabolism in human liver microsomes: potent inhibition by fluvoxamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004270291

Olanzapine pharmacokinetics are similar in Chinese and Caucasian subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004270291

The differential effects of steady-state fluvoxamine on the pharmacokinetics of olanzapine and clozapine in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004270291

Dosing strategies of clozapine-fluvoxamine cotreatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004270291

Pharmacokinetics and pharmacodynamics of clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004270291

Therapeutic drug monitoring of olanzapine: the combined effect of age, gender, smoking, and comedication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004270291

21 January 2018

Identifiers

DOI

10.1177/0091270004270291

1 reference

23 November 2017

1 reference